Figure 2: Ambulatory Blood Pressure Decreased Significantly Immediately After Activation and Remained Lowered by 14.2 mmHg After 3 Months of Therapy
Petr Neuzil, et. al. Pacemaker-Mediated Programmable Hypertension Control Therapy. J Am Heart Assoc. 2017; Dec 23;6(12): e006974. DOI: 10.1161/JAHA.117.006974
Long-term (24-month) data continues to support sustained reduction in systolic blood pressure. In addition, comparison of echocardiograms performed at baseline and following activation up to two years of BackBeat PHC therapy have shown that there are no significant changes in cardiac function (ejection fraction).
Figure 3: Reduction in Systolic Blood Pressure Maintained Chronically
Figure 4: No Significant Changes in Cardiac Function out to 2 Years